In our cohort, approximately one-third of APS patients with thrombosis (n:25) were positive for PC4d, compared to 43% of aPL-positive patients with no aPL-related symptoms (n:7). The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.